However, patients with severe COVID-19 had lower baseline frequencies of marginal zone (MZ) B cells, which produce natural IgM mostly targeting bacterial glycans and are considered an early wave of immune defense (Fig. 3f) (Bonferroni-adjusted P-value range 0.00192–1.84 × 10−4)56. Here, CD40LG is linked to COVID-19.